Diagnosis and Management of Grain-Induced Asthma


Autoria(s): Quirce, Santiago; Díaz Perales, Araceli
Data(s)

01/11/2013

Resumo

Grain-induced asthma is a frequent occupational allergic disease mainly caused by inhalation of cereal flour or powder. The main professions affected are bakers, confectioners, pastry factory workers, millers, farmers, and cereal handlers. This disorder is usually due to an IgE-mediated allergic response to inhalation of cereal flour proteins. The major causative allergens of grain-related asthma are proteins derived from wheat, rye and barley flour, although baking additives, such as fungal α-amylase are also important. This review deals with the current diagnosis and treatment of grain-induced asthma, emphasizing the role of cereal allergens as molecular tools to enhance diagnosis and management of this disorder. Asthma-like symptoms caused by endotoxin exposure among grain workers are beyond the scope of this review. Progress is being made in the characterization of grain and bakery allergens, particularly cereal-derived allergens, as well as in the standardization of allergy tests. Salt-soluble proteins (albumins plus globulins), particularly members of the α-amylase/trypsin inhibitor family, thioredoxins, peroxidase, lipid transfer protein and other soluble enzymes show the strongest IgE reactivities in wheat flour. In addition, prolamins (not extractable by salt solutions) have also been claimed as potential allergens. However, the large variability of IgE-binding patterns of cereal proteins among patients with grain-induced asthma, together with the great differences in the concentrations of potential allergens observed in commercial cereal extracts used for diagnosis, highlight the necessity to standardize and improve the diagnostic tools. Removal from exposure to the offending agents is the cornerstone of the management of grain-induced asthma. The availability of purified allergens should be very helpful for a more refined diagnosis, and new immunomodulatory treatments, including allergen immunotherapy and biological drugs, should aid in the management of patients with this disorder.

Formato

application/pdf

Identificador

http://oa.upm.es/26284/

Idioma(s)

eng

Publicador

E.T.S.I. Agrónomos (UPM)

Relação

http://oa.upm.es/26284/1/INVE_MEM_2013_163247.pdf

http://e-aair.org/search.php?where=aview&id=10.4168/aair.2013.5.6.348&code=9999AAIR&vmode=AONLY

info:eu-repo/semantics/altIdentifier/doi/10.4168/aair.2013.5.6.348

Direitos

http://creativecommons.org/licenses/by-nc-nd/3.0/es/

info:eu-repo/semantics/openAccess

Fonte

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, ISSN 2092-7355, 2013-11, Vol. 5, No. 6

Palavras-Chave #Biología
Tipo

info:eu-repo/semantics/article

Artículo

PeerReviewed